K

Active Director Director DIN 08448877
DIN 08448877 First appointment May 2019 Primary industry Veterinary
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value •••• Premium profile

About Kavita

Data last updated:

Kavita is a Director at Fitbeing Pharmaceuticals Private Limited (since 2019). The company operates in Veterinary. Fitbeing Pharmaceuticals Private Limited reported revenue of ₹25,966 (FY 2023).

DIN 08448877
Primary Designation Director
Industry Veterinary
First Appointment 10 May 2019
Oldest Company Age 7 yrs
Largest company Fitbeing Pharmaceuticals Private Limited · ₹25,966 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20192019₹25,966 (FY 2023)Active

Board colleagues of Kavita

NameDINCompanyDesignation
Rohitesh Pratap Singh08448876Fitbeing Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Fitbeing Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kavita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita

Kavita currently holds 1 directorship: Fitbeing Pharmaceuticals Private Limited (Director, since 10 May 2019, revenue ₹25,966 (FY 2023)).

Kavita was first appointed on 10 May 2019 as Director at Fitbeing Pharmaceuticals Private Limited.

The current boards of Kavita's companies include Rohitesh Pratap Singh (Fitbeing Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available